Pharma-Bio Serv, Inc. (PBSV)
USD 0.38
(-21.86%)
USD 0.38
(-21.86%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.31 Million USD | 30.15% |
| 2022 | 1 Million USD | 148.18% |
| 2021 | -2.08 Million USD | -201.87% |
| 2020 | 2.05 Million USD | -1.74% |
| 2019 | 2.08 Million USD | 63.1% |
| 2018 | 1.27 Million USD | 190.45% |
| 2017 | -1.41 Million USD | -451.46% |
| 2016 | -256.57 Thousand USD | -115.79% |
| 2015 | 1.62 Million USD | -32.68% |
| 2014 | 2.41 Million USD | -50.81% |
| 2013 | 4.9 Million USD | 4.68% |
| 2012 | 4.68 Million USD | 48.37% |
| 2011 | 3.15 Million USD | 749.39% |
| 2010 | 371.91 Thousand USD | -30.45% |
| 2009 | 534.75 Thousand USD | -64.06% |
| 2008 | 1.48 Million USD | -21.74% |
| 2007 | 1.9 Million USD | -18.59% |
| 2006 | 2.33 Million USD | 11776.7% |
| 2005 | -20 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -213.81 Thousand USD | 21.02% |
| 2024 Q3 | -309.19 Thousand USD | -44.61% |
| 2024 Q1 | -270.71 Thousand USD | -474.19% |
| 2023 Q1 | 426.43 Thousand USD | 145.95% |
| 2023 Q4 | -47.14 Thousand USD | -108.96% |
| 2023 Q3 | 526.24 Thousand USD | 30.05% |
| 2023 FY | 1.31 Million USD | 30.15% |
| 2023 Q2 | 404.65 Thousand USD | -5.11% |
| 2022 FY | 1 Million USD | 148.18% |
| 2022 Q3 | 288.03 Thousand USD | 20.0% |
| 2022 Q2 | 240.02 Thousand USD | -21.37% |
| 2022 Q1 | 305.24 Thousand USD | 106.26% |
| 2022 Q4 | 173.37 Thousand USD | -39.81% |
| 2021 Q2 | 240.27 Thousand USD | -10.36% |
| 2021 FY | -2.08 Million USD | -201.87% |
| 2021 Q1 | 268.03 Thousand USD | 85.69% |
| 2021 Q3 | 2.27 Million USD | 846.9% |
| 2021 Q4 | -4.87 Million USD | -314.17% |
| 2020 Q4 | 144.34 Thousand USD | -79.14% |
| 2020 Q1 | 526.9 Thousand USD | 10.32% |
| 2020 FY | 2.05 Million USD | -1.74% |
| 2020 Q2 | 687.56 Thousand USD | 30.49% |
| 2020 Q3 | 692.11 Thousand USD | 0.66% |
| 2019 FY | 2.08 Million USD | 63.1% |
| 2019 Q4 | 477.59 Thousand USD | 10.77% |
| 2019 Q1 | 471.02 Thousand USD | -85.9% |
| 2019 Q2 | 707.48 Thousand USD | 50.2% |
| 2019 Q3 | 431.15 Thousand USD | -39.06% |
| 2018 Q4 | 3.34 Million USD | 357.34% |
| 2018 Q3 | 730.63 Thousand USD | 669.26% |
| 2018 Q2 | -128.34 Thousand USD | 95.18% |
| 2018 Q1 | -2.66 Million USD | -387.0% |
| 2018 FY | 1.27 Million USD | 190.45% |
| 2017 Q4 | -547.02 Thousand USD | -235.64% |
| 2017 Q3 | -162.98 Thousand USD | 49.5% |
| 2017 Q2 | -322.76 Thousand USD | 15.54% |
| 2017 Q1 | -382.13 Thousand USD | 25.56% |
| 2017 FY | -1.41 Million USD | -451.46% |
| 2016 Q3 | -130.47 Thousand USD | -450.72% |
| 2016 Q4 | -513.31 Thousand USD | -293.43% |
| 2016 Q1 | 350.01 Thousand USD | -33.13% |
| 2016 Q2 | 37.2 Thousand USD | -89.37% |
| 2016 FY | -256.57 Thousand USD | -115.79% |
| 2015 Q1 | 288.39 Thousand USD | -65.12% |
| 2015 FY | 1.62 Million USD | -32.68% |
| 2015 Q4 | 523.45 Thousand USD | 15.3% |
| 2015 Q3 | 453.97 Thousand USD | 26.45% |
| 2015 Q2 | 359 Thousand USD | 24.49% |
| 2014 Q3 | 597.06 Thousand USD | 82.15% |
| 2014 Q4 | 826.87 Thousand USD | 38.49% |
| 2014 Q1 | 661.93 Thousand USD | -45.72% |
| 2014 FY | 2.41 Million USD | -50.81% |
| 2014 Q2 | 327.77 Thousand USD | -50.48% |
| 2013 Q4 | 1.21 Million USD | -2.17% |
| 2013 FY | 4.9 Million USD | 4.68% |
| 2013 Q3 | 1.24 Million USD | -10.15% |
| 2013 Q2 | 1.38 Million USD | 31.71% |
| 2013 Q1 | 1.05 Million USD | -2.17% |
| 2012 FY | 4.68 Million USD | 48.37% |
| 2012 Q4 | 1.07 Million USD | -15.62% |
| 2012 Q3 | 1.27 Million USD | 7.4% |
| 2012 Q2 | 1.18 Million USD | 3.62% |
| 2012 Q1 | 1.14 Million USD | 39.07% |
| 2011 Q3 | 1.49 Million USD | 212.41% |
| 2011 Q4 | 824.42 Thousand USD | -44.99% |
| 2011 FY | 3.15 Million USD | 749.39% |
| 2011 Q1 | 356.26 Thousand USD | 94.5% |
| 2011 Q2 | 479.69 Thousand USD | 34.65% |
| 2010 FY | 371.91 Thousand USD | -30.45% |
| 2010 Q2 | 46.88 Thousand USD | 129.14% |
| 2010 Q4 | 183.16 Thousand USD | 50.86% |
| 2010 Q3 | 121.4 Thousand USD | 158.98% |
| 2010 Q1 | 20.45 Thousand USD | -89.46% |
| 2009 Q2 | 267.95 Thousand USD | 1277.92% |
| 2009 Q3 | 53.28 Thousand USD | -80.11% |
| 2009 Q4 | 194.07 Thousand USD | 264.19% |
| 2009 FY | 534.75 Thousand USD | -64.06% |
| 2009 Q1 | 19.44 Thousand USD | -94.36% |
| 2008 Q4 | 345.01 Thousand USD | -32.99% |
| 2008 Q2 | 345.18 Thousand USD | 22.09% |
| 2008 Q1 | 282.72 Thousand USD | -21.23% |
| 2008 FY | 1.48 Million USD | -21.74% |
| 2008 Q3 | 514.87 Thousand USD | 49.16% |
| 2007 FY | 1.9 Million USD | -18.59% |
| 2007 Q4 | 358.91 Thousand USD | -48.32% |
| 2007 Q3 | 694.52 Thousand USD | 34.0% |
| 2007 Q2 | 518.31 Thousand USD | 57.34% |
| 2007 Q1 | 329.41 Thousand USD | -46.32% |
| 2006 Q3 | 352.85 Thousand USD | -25.76% |
| 2006 Q4 | 613.66 Thousand USD | 73.91% |
| 2006 Q2 | 475.25 Thousand USD | 28.59% |
| 2006 FY | 2.33 Million USD | 11776.7% |
| 2006 Q1 | 369.59 Thousand USD | 0.0% |
| 2005 FY | -20 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Achiko AG | -9.32 Million USD | 114.055% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | -5.18 Million USD | 125.245% |
| Cannabis Sativa, Inc. | -1.39 Million USD | 194.107% |
| CompuMed, Inc. | -32.6 Thousand USD | 4118.464% |
| CompuGroup Medical SE & Co. KGaA | 45.91 Million USD | 97.147% |
| Cogstate Limited | 5.44 Million USD | 75.959% |
| CareView Communications, Inc. | -3.95 Million USD | 133.15% |
| Craneware plc | 11.7 Million USD | 88.805% |
| Caduceus Software Systems Corp. | -13.96 Million USD | 109.385% |
| Certive Solutions Inc. | -1.67 Million USD | 178.448% |
| Drug Free Solution, Inc. | -1.4 Million USD | 193.1% |
| DATATRAK International, Inc. | 2.65 Million USD | 50.697% |
| Strainsforpains, Inc. | -182.18 Thousand USD | 819.14% |
| Healixa Inc. | -6.73 Million USD | 119.467% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 7.1 Million USD | 81.555% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | -702.48 Thousand USD | 286.506% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | -789.33 USD | 166086.343% |
| IQ-AI Limited | -623.81 Thousand USD | 310.027% |
| Cannabiz Mobile, Inc. | -750.00 USD | 174790.667% |
| Mednow Inc. | -29.48 Million USD | 104.444% |
| Galileo Life Sciences, Inc. | -248.24 Thousand USD | 627.781% |
| MediXall Group, Inc. | -6.83 Million USD | 119.182% |
| Mitesco, Inc. | -13.33 Million USD | 109.827% |
| MobileSmith, Inc. | -14.12 Million USD | 109.274% |
| NantHealth, Inc. | -67.77 Million USD | 101.933% |
| Net Medical Xpress Solutions, Inc. | -1.85 Million USD | 170.554% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | -13.38 Million USD | 109.788% |
| Patient Access Solutions, Inc. | -10.59 Million USD | 112.368% |
| PPJ Healthcare Enterprises, Inc. | 74.72 Thousand USD | -1653.265% |
| Medical Cannabis Payment Solutions, Inc. | -34.1 Thousand USD | 3942.057% |
| Renalytix Plc | -33.45 Million USD | 103.916% |
| Revium Recovery Inc. | -683 Thousand USD | 291.827% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 313.06 Thousand USD | -318.505% |
| Vaso Corporation | 4.8 Million USD | 72.733% |
| Vynleads, Inc. | -263.43 Thousand USD | 597.341% |